Lysozyme, like many other well-folded globular proteins, under stressful conditions produces nanoscale oligomer assembly and amyloid-like fibrillar aggregates. With engaging Raman microscopy, we made a critical structural analysis of oligomer and other assembly structures of lysozyme obtained from hen egg white and provided a quantitative estimation of a protein secondary structure in different states of its fibrillation. A strong amide I Raman band at 1660 cm(-1) and a N-C alpha-C stretching band at similar to 930 cm(-1) clearly indicated the presence of a substantial amount of alpha-helical folds of the protein in its oligomeric assembly state. In addition, analysis of the amide III region and Raman difference spectra suggested an ample presence of a PPII-like secondary structure in these oligomers without causing major loss of alpha-helical folds, which is found in the case of monomeric samples. Circular dichroism study also revealed the presence of typical alpha-helical folds in the oligomeric state. Nonetheless, most of the Raman bands associated with aromatic residues and disulfide (-S-S-) linkages broadened in the oligomeric state and indicated a collapse in the tertiary structure. In the fibrillar state of assembly, the amide I band became much sharper and enriched with the beta-sheet secondary structure. Also, the disulfide bond vibration in matured fibrils became much weaker compared to monomer and oligomers and thus confirmed certain loss/cleavage of this bond during fibrillation. The Raman band of tryptophan and tyrosine residues indicated that some of these residues experienced a greater hydrophobic microenvironment in the fibrillar state than the protein in the oligomeric state of the assembly structure.
机构:
Karolinska Inst, Dept Lab Med, Stockholm, SwedenKarolinska Inst, Dept Lab Med, Stockholm, Sweden
Bergman, P.
Roan, N. R.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif San Francisco, Dept Urol, San Francisco, CA USA
J David Gladstone Inst, San Francisco, CA USAKarolinska Inst, Dept Lab Med, Stockholm, Sweden
Roan, N. R.
Romling, U.
论文数: 0引用数: 0
h-index: 0
机构:
Karolinska Inst, Dept Microbiol Tumor & Cellbiol, Stockholm, SwedenKarolinska Inst, Dept Lab Med, Stockholm, Sweden
Romling, U.
Bevins, C. L.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif Davis, Sch Med, Dept Microbiol & Immunol, Davis, CA 95616 USAKarolinska Inst, Dept Lab Med, Stockholm, Sweden
Bevins, C. L.
Muench, J.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Ulm, Inst Mol Virol, Med Ctr, Ulm, Germany
Univ Ulm, Ulm Peptide Pharmaceut, Ulm, GermanyKarolinska Inst, Dept Lab Med, Stockholm, Sweden
机构:
Karolinska Inst, Dept Lab Med, Stockholm, SwedenKarolinska Inst, Dept Lab Med, Stockholm, Sweden
Bergman, P.
Roan, N. R.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif San Francisco, Dept Urol, San Francisco, CA USA
J David Gladstone Inst, San Francisco, CA USAKarolinska Inst, Dept Lab Med, Stockholm, Sweden
Roan, N. R.
Romling, U.
论文数: 0引用数: 0
h-index: 0
机构:
Karolinska Inst, Dept Microbiol Tumor & Cellbiol, Stockholm, SwedenKarolinska Inst, Dept Lab Med, Stockholm, Sweden
Romling, U.
Bevins, C. L.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif Davis, Sch Med, Dept Microbiol & Immunol, Davis, CA 95616 USAKarolinska Inst, Dept Lab Med, Stockholm, Sweden
Bevins, C. L.
Muench, J.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Ulm, Inst Mol Virol, Med Ctr, Ulm, Germany
Univ Ulm, Ulm Peptide Pharmaceut, Ulm, GermanyKarolinska Inst, Dept Lab Med, Stockholm, Sweden